Human airway model reveals why babies develop severe RSV

Human airway model reveals why babies develop severe RSV Researchers find that infant airway tissue actively shapes the immune response to RSV, suggesting future therapies should target both the virus and inflammation. Written byBree Foster, PhD https://www.drugdiscoverynews.com/human-airway-model-reveals-why-babies-develop-severe-rsv-17333?utm_campaign=DDN_Newsletter_Dose&utm_medium=email&_hsenc=p2ANqtz-_DykP2Osc0SJfgtPqArDXrNBMrfTCF0K1MeR9BhAiWvrgs6coqYA7kf1WMNLpadxAIcTdiWiizNTwMYSWcYA2aItue7w&_hsmi=429281211&utm_content=429281211&utm_source=hs_email Respiratory syncytial virus (RSV) is the leading cause of severe lower respiratory tract infections in infants, accounting for an estimated 3.6 million hospitalizations worldwide and more than 100,000 deaths in children under five each year. Although preventive antibodies have improved protection for vulnerable infants, treatment options once babies become seriously ill remain largely limited to supportive care.